Three major activities of IL-10 contribute to these paradoxical outcomes: 1) promoting the proliferation and activity of cytotoxic T-lymphocytes (CTLs); 2) inhibiting antigen presentation and production of proinflammatory cytokines from APCs; and 3) alleviating chronic inflammation–mediated tumor promoting effects (35). The gene discussed is IL10; the disease is neoplasm.